Skip to main content

H.R. 2391

Referred to Committee

Medicaid Generic Drug Price Fairness Act of 2015

Introduced 5/18/2015•114th Congress•House

Latest Action

Referred to the Subcommittee on Health.

5/22/2015 • House

Summary

Medicaid Generic Drug Price Fairness Act of 2015

This bill amends title XIX (Medicaid) of the Social Security Act to increase the amount of rebate with respect to each generic drug in the manner that the rebate for a dosage form and strength of a single source drug or an innovator multiple source drug is increased, except as provided in special application rules, including a special rule for certain noninnovator multiple source drugs.

Introduced in House • 5/18/2015

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
MedicaidPrescription drugs

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (11)

Party Breakdown

11
Democrats
0
Republicans
0
Independents

Sponsor

R[
Rep. Cummings, Elijah E. [D-MD-7]

Democrat • MD-7

Sponsored 5/18/2015

Cosponsors (10)

R[
Rep. Levin, Sander M. [D-MI-9]

D-MI-9

Joined 5/21/2015

R[
Rep. Sarbanes, John P. [D-MD-3]

D-MD-3

Joined 7/13/2015

R[
Rep. Edwards, Donna F. [D-MD-4]

D-MD-4

Joined 7/22/2015

R[
Rep. Brown, Corrine [D-FL-5]

D-FL-5

Joined 7/22/2015

R[
Rep. DeSaulnier, Mark [D-CA-11]

D-CA-11

Joined 7/23/2015

Bill Journey

Originated in the House

Introduced

May 18, 2015

Referred to the House Committee on Energy and Commerce.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House5/18/2015

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors10